|
1
|
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.
|
Arch Gen Psychiatry
|
2008
|
3.28
|
|
2
|
Anticorrelations in resting state networks without global signal regression.
|
Neuroimage
|
2011
|
3.07
|
|
3
|
Low glial numbers in the amygdala in major depressive disorder.
|
Biol Psychiatry
|
2002
|
1.86
|
|
4
|
Abnormal medial prefrontal cortex resting-state connectivity in bipolar disorder and schizophrenia.
|
Neuropsychopharmacology
|
2011
|
1.68
|
|
5
|
Myelin and axon abnormalities in schizophrenia measured with magnetic resonance imaging techniques.
|
Biol Psychiatry
|
2013
|
1.64
|
|
6
|
CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy.
|
Psychopharmacology (Berl)
|
2011
|
1.57
|
|
7
|
Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole.
|
Neuropsychopharmacology
|
2009
|
1.36
|
|
8
|
Quantification of J-resolved proton spectra in two-dimensions with LCModel using GAMMA-simulated basis sets at 4 Tesla.
|
NMR Biomed
|
2009
|
1.26
|
|
9
|
Delirious mania: clinical features and treatment response.
|
J Affect Disord
|
2008
|
1.11
|
|
10
|
Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.
|
Neuropsychopharmacology
|
2010
|
1.00
|
|
11
|
Catatonia in psychotic patients: clinical features and treatment response.
|
J Neuropsychiatry Clin Neurosci
|
2011
|
0.98
|
|
12
|
Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses.
|
Eur Neuropsychopharmacol
|
2004
|
0.95
|
|
13
|
Functional connectivity of left Heschl's gyrus in vulnerability to auditory hallucinations in schizophrenia.
|
Schizophr Res
|
2012
|
0.93
|
|
14
|
Brain metabolite concentrations across cortical regions in healthy adults.
|
Brain Res
|
2010
|
0.91
|
|
15
|
Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses.
|
Schizophr Res
|
2011
|
0.90
|
|
16
|
Creatine kinase and ATP synthase reaction rates in human frontal lobe measured by ³¹P magnetization transfer spectroscopy at 4T.
|
Magn Reson Imaging
|
2012
|
0.89
|
|
17
|
Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder.
|
Psychiatry Res
|
2011
|
0.86
|
|
18
|
Perceptual training strongly improves visual motion perception in schizophrenia.
|
Brain Cogn
|
2011
|
0.86
|
|
19
|
Tactile, olfactory, and gustatory hallucinations in psychotic disorders: a descriptive study.
|
Ann Acad Med Singapore
|
2009
|
0.85
|
|
20
|
Probing myelin and axon abnormalities separately in psychiatric disorders using MRI techniques.
|
Front Integr Neurosci
|
2013
|
0.83
|
|
21
|
Neurophysiologic effect of GWAS derived schizophrenia and bipolar risk variants.
|
Am J Med Genet B Neuropsychiatr Genet
|
2013
|
0.83
|
|
22
|
Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorder.
|
Bipolar Disord
|
2013
|
0.81
|
|
23
|
Exploring the role of central astrocytic glutamate uptake in ethanol reward in mice.
|
Alcohol Clin Exp Res
|
2014
|
0.80
|
|
24
|
Categorical vs dimensional classifications of psychotic disorders.
|
Compr Psychiatry
|
2012
|
0.79
|
|
25
|
Gray matter volume in schizophrenia and bipolar disorder with psychotic features.
|
Schizophr Res
|
2012
|
0.79
|
|
26
|
Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up.
|
Schizophr Res
|
2013
|
0.77
|